Sign up to save your podcasts
Or
Share FOURIER: How Low Should LDL Go?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FOURIER: How Low Should LDL Go?
What should primary care docs know about LDL-lowering effects of the PCSK9 inhibitor evolocumab? A leading cardiologist discusses results of the FOURIER trial.
View all episodes
By MedscapeWhat should primary care docs know about LDL-lowering effects of the PCSK9 inhibitor evolocumab? A leading cardiologist discusses results of the FOURIER trial.